LRP5 has been reported to be involved in mediating Wnt/β-catenin signaling in skeletal metastasis prostate cancer (PC) due to the increased levels of Wnt-1 and β-catenin proteins in both PC cell lines and primary specimens [95]. The gene discussed is LRP5; the disease is pachyonychia congenita.